Patents by Inventor David L. Baillie

David L. Baillie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids encoding mammalian T-type calcium channels
    Patent number: 7517672
    Abstract: Sequences and partial sequences for three types of mammalian (human and rat sequences identified) T-type calcium channel subunits which we have labeled as the ?1G, ?1H and ?1I subunits are provided. Knowledge of the sequence of these calcium channel permits the localization and recovery of the complete sequence from human cells, and the development of cell lines which express the novel calcium channels of the invention. These cells may be used for identifying compounds capable of acting as agonists or antagonists to the calcium channels.
    Type: Grant
    Filed: January 3, 2007
    Date of Patent: April 14, 2009
    Assignee: Neuromed Pharmaceuticals Ltd.
    Inventors: Terrance P. Snutch, David L. Baillie
  • Nucleic acids encoding mammalian T-type calcium channels
    Patent number: 7501263
    Abstract: Sequences and partial sequences for three types of mammalian (human and rat sequences identified) T-type calcium channel subunits which we have labeled as the ?1G, ?1H and ?1I subunits are provided. Knowledge of the sequence of these calcium channel permits the localization and recovery of the complete sequence from human cells, and the development of cell lines which express the novel calcium channels of the invention. These cells may be used for identifying compounds capable of acting as agonists or antagonists to the calcium channels.
    Type: Grant
    Filed: January 3, 2007
    Date of Patent: March 10, 2009
    Assignee: Neuromed Technologies, Inc.
    Inventors: Terrance P. Snutch, David L. Baillie
  • Methods for identifying agonists and antagonists of human T-type calcium channels
    Patent number: 7297504
    Abstract: Sequences and partial sequences for three types of mammalian (human and rat) sequences identified) T-type calcium channel subunits which we have labeled as the ?1G, ?1H and ?1I subunits are provided. Knowledge of the sequence of these calcium channel permits the localization and recovery of the complete sequence from human cells, and the development of cell lines which express the novel calcium channels of the invention. These cells may be used for identifying compounds capable of acting as agonists or antagonists to the calcium channels.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: November 20, 2007
    Assignee: Neuromed Pharmaceuticals Ltd.
    Inventors: Terry P. Snutch, David L. Baillie
  • DNA encoding mammalian T-type calcium channels
    Patent number: 7157243
    Abstract: Sequences and partial sequences for three types of mammalian (human and rat sequences identified) T-type calcium channel subunits which we have labeled as the ?1G, ?1H and ?1I subunits are provided. Knowledge of the sequence of these calcium channel permits the localization and recovery of the complete sequence from human cells, and the development of cell lines which express the novel calcium channels of the invention. These cells may be used for identifying compounds capable of acting as agonists or antagonists to the calcium channels.
    Type: Grant
    Filed: July 6, 2000
    Date of Patent: January 2, 2007
    Assignee: Neuromed Pharmaceuticals Ltd.
    Inventors: Terrance P. Snutch, David L. Baillie